{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:14:32Z","timestamp":1778901272030,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA199338-02"],"award-info":[{"award-number":["U01 CA199338-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K22 CA234400"],"award-info":[{"award-number":["K22 CA234400"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016945","name":"Sidney Kimmel Center for Prostate and Urologic Cancers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006280","name":"Urology Care Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:11:18Z","timestamp":1757185878000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Race and Detection of Clinically Significant Prostate Cancer in Transperineal and Transrectal Biopsies"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1692-4171","authenticated-orcid":false,"given":"Suma","family":"Gangidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Wald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Oakley","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.08.001_b0005","unstructured":"National Cancer Institute. Cancer Stat Facts: Prostate Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html."},{"key":"10.1016\/j.euo.2025.08.001_b0010","doi-asserted-by":"crossref","first-page":"34.e9","DOI":"10.1016\/j.urolonc.2013.01.003","article-title":"Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?","volume":"32","author":"Hudson","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0015","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1200\/JCO.22.02203","article-title":"Racism does not cause prostate cancer, it causes prostate cancer death","volume":"41","author":"Vickers","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.08.001_b0025","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jamaoncol.2024.4000","article-title":"Transperineal vs transrectal prostate biopsy\u2014the PREVENT randomized clinical trial","volume":"10","author":"Hu","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(25)00100-7","article-title":"Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial","volume":"26","author":"Bryant","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1097-0045(19981201)37:4<230::AID-PROS4>3.0.CO;2-L","article-title":"Racial differences and prognostic significance of tumor location in radical prostatectomy specimens","volume":"37","author":"Tiguert","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.08.001_b0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.urology.2021.07.005","article-title":"African American men have increased risk of prostate cancer detection despite similar rates of anterior prostatic lesions and PI-RADS grade on multiparametric magnetic resonance imaging","volume":"163","author":"Patel","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.08.001_b0045","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/curroncol28040212","article-title":"Prostate cancer lesions by zone and race: does multiparametric MRI demonstrate racial difference in prostate cancer lesions for African American men?","volume":"28","author":"Koller","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071191","article-title":"Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectious complications","volume":"13","author":"Hu","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.euo.2025.08.001_b0055","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.euo.2024.01.019","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted biopsies for prostate cancer diagnosis: final results of the randomized PERFECT trial (CCAFU-PR1)","volume":"7","author":"Ploussard","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2013.06.021","article-title":"Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in Black American men","volume":"191","author":"Sundi","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.08.001_b0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.juro.2018.10.003","article-title":"Effect of lesion location on prostate cancer detection rate with magnetic resonance imaging targeted biopsy in African Americans","volume":"201","author":"Walton","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.08.001_b0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.08.001_b0075","doi-asserted-by":"crossref","first-page":"254.e15","DOI":"10.1016\/j.urolonc.2015.12.018","article-title":"The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men","volume":"34","author":"Kongnyuy","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0080","doi-asserted-by":"crossref","first-page":"336.e1","DOI":"10.1016\/j.urolonc.2016.03.017","article-title":"Racial variation in prostate needle biopsy templates directed anterior to the peripheral zone","volume":"34","author":"Feibus","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.08.001_b0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.euf.2023.07.011","volume":"10","author":"Scuderi","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.08.001_b0090","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/cncr.34981","article-title":"The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy","volume":"129","author":"Gaffney","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.08.001_b0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2021.06.026","article-title":"Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer","volume":"80","author":"Vickers","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.08.001_b0100","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00345-016-1788-4","article-title":"Clinical impact of prostate biopsy undergrading in an academic and community setting","volume":"34","author":"Mortezavi","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.08.001_b0105","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1475-6773.2006.00551.x","article-title":"Use of geocoding and surname analysis to estimate race and ethnicity","volume":"41","author":"Fiscella","year":"2006","journal-title":"Health Serv Res"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:36:36Z","timestamp":1778898996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2588931125002214"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.08.001","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Race and Detection of Clinically Significant Prostate Cancer in Transperineal and Transrectal Biopsies","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}